UCART19 Lymphoblastic Leukemia Drug - Business-News-Today.com

🧬 Interested in pharma, biotech and medical device news? Visit PharmaDeviceNews.com →

Business news, market intelligence, and global industry analysis.

The Latest

CXMT is reportedly preparing a NAND flash research and development production line in Beijing as the newly listed Chinese memory-chip company expands beyond DRAM. Representative image.

CXMT targets NAND flash as $8.6bn IPO gives China’s memory champion room to expand

Morgan Stanley’s North Haven Private Income Fund is working through another oversubscribed repurchase offer as private-credit liquidity demand remains elevated. Representative image.

Morgan Stanley private credit fund again gets withdrawal requests above its 5% limit

OpenAI reportedly expects hundreds of billions of dollars of negative free cash flow as it finances massive computing and data-centre expansion through 2030. Representative image.

OpenAI’s reported $278bn cash burn reveals the financing scale behind frontier AI

Taboola.com Ltd. has agreed to acquire finance-focused advertising technology company Dianomi plc for £19 million in guaranteed cash consideration and up to £27 million including contingent payments. Representative image.

Taboola offers up to £27m for Dianomi as AI reshapes digital advertising

Read More

Pharma Industry News

FDA clears Servier and Pfizer for clinical development of UCART19 for acute lymphoblastic leukemia

Servier and Pfizer Inc. have received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration…

bypharmanewsdaily

March 12, 2017

web analytics